Proteolysis-concentrating on chimeras (PROTACs) and molecular glue degraders (MGDs) are the most maturely designed TPD tactics. Within this review, we target both preclinical experiments and clinical trials to offer a comprehensive summary of the safety and medical success of PROTACs and MGDs in hematologic malignancies over the past two decades. https://ro-512676600876.blogspothub.com/31255099/facts-about-ravoxertinib-revealed